Developments in MS over the Past 17 Years the MS Forum and The International MS Journal

Area of Science:

• Neurology
• Immunology
• Neuroscience

Background:

• Multiple sclerosis (MS) was poorly understood and recognized in the early 1990s.
• Therapeutic interest and pharmaceutical investment in MS were minimal.
• Key challenges included the disease's unknown etiology and lack of effective treatments.

Purpose of the Study:

• To highlight the historical context of multiple sclerosis research and treatment at the time of the journal's inception.
• To underscore the limited scientific and clinical understanding of MS in 1994.
• To set the stage for the journal's role in advancing MS knowledge.

Main Methods:

• Historical review of the status of multiple sclerosis research.
• Analysis of the therapeutic landscape for MS in the mid-1990s.
• Examination of the perceived prevalence and impact of MS.

Main Results:

• MS was considered an under-recognized condition with limited scientific investigation.
• Pharmaceutical companies showed little interest due to the disease's rarity and lack of therapeutic targets.
• The causal factors of MS remained largely unknown, hindering treatment development.

Conclusions:

• The early 1990s represented a period of low scientific and therapeutic engagement with multiple sclerosis.
• The International MS Journal was founded during a time when MS was a neglected disease.
• Significant advancements in understanding and treating MS were needed.